CNK Cinemark Holdings, Inc. Insider Trading

Director Zoradi Mark sold 150,000 CNK shares (34% of holdings) for $4.4M as stock trades well below 52-week highs.

Zoradi Mark, a Cinemark director, sold approximately one-third of his stake in a single transaction, reducing his holdings substantially. The timing is notable: his two prior sales at this company were both well-timed, with the stock declining in both the near and longer term after each exit, suggesting he has a track record of selling before downturns at Cinemark specifically. The current sale occurs as the stock trades meaningfully below its 52-week high, and the company, while still profitable and growing revenue, posted a net loss in the most recent quarter—a shift from profitability. This is the third open-market sale Mark has made at Cinemark in the past three years, showing a consistent pattern of reducing rather than building his position in the company.

Director Mark Zoradi sells 85,229 shares at $32.38 on 2024-11-21 under 10b5-1 plan adopted 2024-08-22

Mark Zoradi (Director) executed 2 separate sales totaling 87,229 shares for $2,792,055.02 as part of a pre-arranged 10b5-1 trading plan adopted on 2024-08-22. The largest transaction was 85,229 shares sold at $32.38 on 2024-11-21. This follows a prior history of open-market activity at Cinemark: 6 purchases totaling 50,000 shares for $1,078,550.00 between 2017 and 2020, as well as a small 2,000-share sale in December 2020. The director's post-transaction holdings of 436,608 shares represent a net reduction of 37,229 shares (-7.9% vs pre-transaction holdings). Since this sale is scheduled under a 10b5-1 plan rather than discretionary, the timing and sequence of liquidation are predetermined rather than reflecting real-time conviction about valuation.

CFO Thomas Melissa sold 22,082 shares of CNK at $24.81 on 2025-12-10; holdings decline to 167,360 shares.

Thomas Melissa, EVP and Chief Financial Officer, sold 22,082 shares (22.1K shares) at $24.81, reducing his holdings by 11.7% to 167,360 shares. The sale occurs in a context where the stock has declined 28.8% from its 52-week high of $35.18 and 17.6% over the past 30 days, though the company reported net income of $49,500,000 against revenue of $857,500,000 in the latest quarter. This represents a material reduction in the CFO's ownership stake at a point when the stock has experienced significant downward price pressure, providing a factual data point about insider positioning during a period of weakness.

Gierhart sold 52,524 shares of CNK at $31.85; stock now at $31.94 after 90-day rise of +27.7%

Wanda Marie Gierhart, Chief Marketing & Content Officer, sold 52,524 shares at $31.85 on 2025-06-13, reducing her holdings from 147,414 shares to 94,890 shares (-35.6% of prior position). The sale occurred during a period of strong momentum: the stock has risen +27.7% over the prior 90 days and is currently trading at $31.94, just 0.3% above the transaction price. However, CNK's underlying fundamentals show deterioration: the latest quarter posted net income of $-38,900,000.00 against revenue of $540,700,000.00, and annual revenue growth stands at -0.6%. The stock trades at a P/E of 15.66 and a market cap of $3,846,373,637.62, but remains -11.3% from its 52-week high of $36.02. The sale represents a material reduction in a senior executive's stake during a recovery phase following declining fundamentals.

CEO Sean Gamble sold 127,672 shares of CNK at $34.85 (Dec 6); holds 655,104 shares post-sale. Stock near 52-week high.

Sean Gamble, CEO of Cinemark Holdings, sold 127,672 shares at $34.85 on 2024-12-06, reducing his stake by 16.3% from 782,776 to 655,104 shares. The transaction price of $34.85 is near the 52-week high of $36.02, with the stock currently at $33.61. The company's fundamentals are solid: revenue of $921,800,000 with net income of $187,800,000, annual revenue growth of +24.9%, and a P/E of 6.20. The sale occurred while the stock was within 6.7% of its 52-week high and up 19.1% over 90 days, suggesting the CEO executed a material reduction of personal holdings at an elevated price point relative to recent trading history.

EVP-General Counsel sold 27,897 shares at blended $35.53 for $991.2K; retains 329.5K shares post-sale.

Cavalier Michael, EVP and General Counsel at Cinemark Holdings, executed 2 separate sales totaling 27,897 shares for $991,233.43 on December 5–6, 2024, at prices near the current market level of $35.18. This represents a 7.8% reduction in his post-transaction holdings of 329.5K shares. The transaction occurred as CNK trades within 2.3% of its 52-week high and has delivered strong recent momentum (+14.4% over 30 days, +25.2% over 90 days), alongside robust financial fundamentals: $921.8M revenue in the latest quarter, net income of $187.8M, annual revenue growth of +24.9%, and a compressed P/E of 6.49. The sale occurred during a period of substantial stock appreciation and healthy operational performance, but without flagged scheduling information or prior pattern context, the transaction signal remains ambiguous.

Cinemark director Mark Zoradi sold 85,229 shares (85.2K) at $32.38 on 2024-11-21 for $2.8M, reducing stake by 16.1%

Director Mark Zoradi executed a sale of 85,229 shares (85.2K) at $32.38 on 2024-11-21, reducing his holdings from 529.2K to 444.0K shares and realizing $2.8M in proceeds. The transaction occurred near the 52-week high of $33.45, with the stock at current price of $32.63 showing +15.1% over 30 days and +17.4% over 90 days. Cinemark's fundamentals remain solid with annual revenue growth of +24.9%, net income of $187.8M, and a low P/E of 6.02, suggesting the company is not in distress. The sale represents a meaningful but not complete exit from his position, removing 16.1% of his pre-transaction holdings at a price point consistent with recent strength in the stock. This is the second transaction of record for this insider, with limited history available to assess any broader trading pattern at this ticker.